• Return to Headlines

Quest Diagnostic Up 9.2% Since SmarTrend Uptrend Call (DGX)

By James Quinn

SmarTrend identified an Uptrend for Quest Diagnostic (NYSE:DGX) on April 24th, 2019 at $94.36. In approximately 6 months, Quest Diagnostic has returned 9.19% as of today's recent price of $103.03.

In the past 52 weeks, Quest Diagnostic share prices have been bracketed by a low of $78.95 and a high of $107.97 and are now at $103.03, 31% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has remained constant.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Quest Diagnostic shares.

Log in and add Quest Diagnostic (DGX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights quest diagnostic

Ticker(s): DGX